Muscarinic Agonist-Mediated Heterologous Desensitization in Isolated Ileum Requires Activation of Both Muscarinic M2 and M3 Receptors
- 1 January 2004
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 308 (1) , 339-349
- https://doi.org/10.1124/jpet.103.055327
Abstract
We investigated the subtypes of the muscarinic receptor mediating short-term heterologous desensitization in the isolated ileum. Treatment of the ileum from C57BL/6 mice with acetylcholine (30 μM) for 20 min caused a subsequent decrease in contractile sensitivity to both prostaglandin F2α (PGF2α) and the muscarinic agonist, oxotremorine-M. This subsensitivity was characterized by 7- and 3-fold increases in the EC50 values of the agonists, respectively, with no significant effect on the maximal response. The subsensitivity to PGF2α was prevented in both M2 and M3 muscarinic receptor knockout mice. Similarly, the subsensitivity to oxotremorine-M was prevented in M2 knockout mice. Acetylcholine-mediated desensitization of histamine-induced contractions in the guinea pig ileum was inhibited by both M2- and M3-selective muscarinic antagonists with high potency, although careful analysis of the data suggested behavior more consistent with an M2 antagonistic profile. Modeling studies showed that the competitive antagonism of response contingent upon activation of two receptor subtypes should exhibit a pharmacological profile similar to that of the least sensitive signaling pathway. Our results demonstrate that muscarinic agonist-mediated short-term heterologous desensitization of intestinal smooth muscle is contingent upon activation of both M2 and M3 muscarinic receptors and that activation of either receptor by itself is insufficient to cause desensitization.This publication has 46 references indexed in Scilit:
- Pharmacological Analysis of the Contractile Role of M 2 and M 3 Muscarinic Receptors in Smooth MuscleReceptors and Channels, 2003
- Increased Relaxant Action of Forskolin and Isoproterenol against Muscarinic Agonist-Induced Contractions in Smooth Muscle from M2 Receptor Knockout MiceThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Functional role of muscarinic M2 receptors in α,β -methylene ATP induced, neurogenic contractions in guinea-pig ileumBritish Journal of Pharmacology, 2000
- SUBTYPES OF THE MUSCARINIC RECEPTOR IN SMOOTH MUSCLELife Sciences, 1997
- Activation of M2 muscarinic receptors in guinea-pig ileum opens cationic channels modulated by M3 muscarinic receptorsLife Sciences, 1997
- Binding studies on two functional cardioselective antimuscarinic compoundsJournal of Pharmacy and Pharmacology, 1988
- Failure of gallamine and pancuronium to inhibit selectively (−)-[3H]quinuclidinyl benzilate binding in guinea-pig atriaCanadian Journal of Physiology and Pharmacology, 1985
- Operational models of pharmacological agonismProceedings of the Royal Society of London. B. Biological Sciences, 1983
- COMPARISON OF DISSOCIATION CONSTANTS AND OF RELATIVE EFFICACIES OF SELECTED AGONISTS ACTING ON PARASYMPATHETIC RECEPTORS*Annals of the New York Academy of Sciences, 1967
- A theory of drug action based on the rate of drug-receptor combinationProceedings of the Royal Society of London. B. Biological Sciences, 1961